单侧肋下前路腰方肌阻滞与鞘内吗啡用于腹腔镜肾切除术后镇痛:随机对照试验
单中心随机观察者盲非劣效试验纳入80例择期腹腔镜肾切除成人,比较单次单侧肋下前路腰方肌阻滞与鞘内吗啡(5 mcg/kg,最大200 mcg)的24小时累积静脉吗啡毫克当量。腰方肌阻滞组24小时静脉吗啡毫克当量中位差值9.5 mg(95%CI 7至12;p<0.001),超过非劣效界值,未达非劣效;鞘内吗啡组24小时及出院时疼痛评分更低、满意度更高,30天并发症及恶心、瘙痒、呼吸事件无组间差异。
要点
- 肋下前路腰方肌阻滞未达非劣效界值,24小时静脉吗啡毫克当量中位差值9.5 mg。
- 鞘内吗啡组24小时和出院时疼痛评分更低、满意度更高。
- 两组30天并发症及恶心、瘙痒、呼吸事件无差异。
核心结论
- 尽管设计为非劣效试验,肋下前路腰方肌阻滞未达到非劣效阈值。
- 鞘内吗啡组阿片用量更低,但研究未设计优效性检验。
- 肋下前路腰方肌阻滞可考虑用于有鞘内吗啡相关呼吸抑制风险的患者。
研究设计与样本
- 单中心、随机、观察者盲、非劣效试验,纳入80例择期腹腔镜肾切除成人。
- 肋下前路腰方肌阻滞组:单次单侧注射0.25%布比卡因(0.4 mL/kg)含肾上腺素1:400,000。
- 鞘内吗啡组:脊麻下给予5 mcg/kg鞘内吗啡(最大200 mcg)加7.5 mg等比重布比卡因。
- 主要结局为24小时累积静脉吗啡毫克当量(MME)。
主要发现
- 肋下前路腰方肌阻滞与鞘内吗啡24小时静脉MME中位差值为9.5 mg(95%CI 7至12;p<0.001),超过非劣效界值。
- 鞘内吗啡组24小时疼痛评分更低:中位数(Q1-Q3)108(102.25-113.5)vs 肋下前路腰方肌阻滞75.5(58-100)。
- 鞘内吗啡组出院时满意度更高:117(115-123.75)vs 94(77-110);p<0.001。
- 30天并发症率(Clavien-Dindo和综合并发症指数评分)及恶心、瘙痒、呼吸事件等不良反应组间无差异。
关键数值与推荐
- 非劣效界值未在原文摘要中报告具体数值,仅报告中位差值9.5 mg(95%CI 7至12;p<0.001)超过该界值。
- 鞘内吗啡剂量为5 mcg/kg(最大200 mcg),联合7.5 mg等比重布比卡因。
- 肋下前路腰方肌阻滞使用0.25%布比卡因0.4 mL/kg,含肾上腺素1:400,000。
临床怎么用
- 肋下前路腰方肌阻滞未达非劣效,不能常规替代鞘内吗啡用于腹腔镜肾切除术后镇痛。
- 对鞘内吗啡相关呼吸抑制风险高的患者,可考虑肋下前路腰方肌阻滞。
- 抗凝患者需谨慎,因该阻滞解剖位置深。
- 肋下前路腰方肌阻滞头侧扩散不稳定且内脏镇痛有限,可能解释其疗效较低。
局限性
- 研究未设计优效性检验,无法确立鞘内吗啡优于肋下前路腰方肌阻滞。
- 原文摘要未报告非劣效界值具体数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intrathecal morphine (ITM) offers effective analgesia after laparoscopic nephrectomy but may cause side effects. The anterior subcostal quadratus lumborum (QL) block has been proposed as a safer alternative. This study evaluated whether anterior subcostal QL block is non-inferior to ITM in reducing postoperative opioid use. METHODS: This single-center, randomized, observer-blinded, non-inferiority trial allocated 80 adult patients undergoing elective laparoscopic nephrectomy to receive single-injection unilateral anterior subcostal QL block (0.25% bupivacaine (0.4 mL/kg) containing epinephrine 1:400,000) or spinal anesthesia with 5 mcg/kg ITM (maximum 200 mcg) plus 7.5 mg isobaric bupivacaine. The primary outcome was the 24-hour cumulative intravenous morphine milligram equivalent (MME). Pain scores were recorded at rest and during activity at 0, 3, 6, 12, and 24 hours postoperatively. Patient satisfaction, recovery quality, and adverse effects were also evaluated. RESULTS: The median difference in 24 hours intravenous MME consumption between anterior subcostal QL block and ITM was 9.5 mg (95% CI 7 to 12; p<0.001), exceeding the non-inferiority margin. Patients with ITM reported lower pain scores and greater satisfaction at 24 hours (median (Q1-Q3), ITM 108 (102.25-113.5) vs anterior subcostal QL block 75.5 (58-100)) and discharge (ITM 117 (115-123.75) vs anterior subcostal QL block 94 (77-110); p<0.001). However, no between-group differences were observed in 30-day complication rates, including the Clavien-Dindo and Comprehensive Complication Index scores. Adverse effects, such as nausea, pruritus, and respiratory events, were comparable. CONCLUSIONS: Although designed as a non-inferiority trial, anterior subcostal QL block did not meet the threshold. While ITM resulted in lower opioid use, the study was not powered to establish superiority. Anterior subcostal QL block may be considered for patients at risk of ITM-related respiratory depression; however, its inconsistent cranial spread and limited visceral analgesia may explain its lower efficacy. Caution is also required in anticoagulated patients because of the deep anatomical location of the block. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT06630858.
引用
- Kaya C, Dost B, Turunc E, et al. Unilateral subcostal anterior quadratus lumborum block versus intrathecal morphine for postoperative pain in laparoscopic nephrectomy: a randomized controlled trial. Reg Anesth Pain Med. 2025. PMID: 40639953. doi:10.1136/rapm-2025-106844
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。